ECIO meets ILCA
HCC and biliary tract cancer: combining forces, shaping the future
Saturday, May 1, 14:30-16:00
Moderators: Stephen Chan (Hong Kong/HK), Martijn Meijerink (Amsterdam/NL)
Combined therapies in HCC: lessons from RCTs
Stephen Chan (Hong Kong/HK)
HCC trials: what comes next?
Julius Chapiro (New Haven/US)
Discussion: what will make the next trials practice-changing?
Panel
Systemic therapy in biliary tract cancer: state of the art
Lorenza Rimassa (Milan/IT)
Getting started right: biopsy and biliary stenting
Otto van Delden (Amsterdam/NL)
Discussion: where do loco-regional therapies fit in?
Panel
About ILCA
The International Liver Cancer Association (ILCA), was founded in 2007 and is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines. Its mission is to lead a global community of physicians, scientists and allied professionals through education and research with the goal to better prevent and treat liver cancer.
